Randomised, double-blind, placebo-controlled, two-way crossover phase IIa proof-of-concept trial of orally administered tianeptine [REV 001] in alfentanil-induced respiratory depression

Trial Profile

Randomised, double-blind, placebo-controlled, two-way crossover phase IIa proof-of-concept trial of orally administered tianeptine [REV 001] in alfentanil-induced respiratory depression

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Jun 2014

At a glance

  • Drugs Tianeptine (Primary)
  • Indications Respiratory insufficiency
  • Focus Adverse reactions; Proof of concept; Therapeutic Use
  • Sponsors Revive Therapeutics
  • Most Recent Events

    • 27 Jun 2014 Results published in the Revive Therapeutic Media Release.
    • 18 Feb 2014 New trial record
    • 12 Feb 2014 Interim results published in a Revive Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top